2.50
Hdl Handle:
http://hdl.handle.net/10541/69758
Title:
Testis cancer: the UK as a model.
Authors:
Maddineni, Satish B; Clarke, Noel W ( 0000-0001-7776-8059 )
Abstract:
Over the course of the past 30 years progress in identification of risk factors, improvements in therapy regimens and advances in treatment delivery have all served to render testis cancer a treatable and survivable malignancy. Institution of specialised oncology centres in the UK to address treatment options for urological cancers has proven to be an effective approach to managing testis cancer by drawing on interdisciplinary expertise and applying insights gained from ongoing R&D. This strategy could become a model for treating other cancers as well.
Affiliation:
Urological Oncology, The Christie Hospital NHS Foundation Trust, Wilmslow Road, M20 4BX, Manchester, England.
Citation:
Testis cancer: the UK as a model., 2009, 48 (4):386-92 Urologe A
Journal:
Der Urologe. Ausg. A
Issue Date:
Apr-2009
URI:
http://hdl.handle.net/10541/69758
DOI:
10.1007/s00120-009-1949-9
PubMed ID:
19352606
Type:
Article
Language:
de
ISSN:
0340-2592
Appears in Collections:
All Christie Publications ; Urological Oncology

Full metadata record

DC FieldValue Language
dc.contributor.authorMaddineni, Satish B-
dc.contributor.authorClarke, Noel W-
dc.date.accessioned2009-06-05T09:35:14Z-
dc.date.available2009-06-05T09:35:14Z-
dc.date.issued2009-04-
dc.identifier.citationTestis cancer: the UK as a model., 2009, 48 (4):386-92 Urologe Aen
dc.identifier.issn0340-2592-
dc.identifier.pmid19352606-
dc.identifier.doi10.1007/s00120-009-1949-9-
dc.identifier.urihttp://hdl.handle.net/10541/69758-
dc.description.abstractOver the course of the past 30 years progress in identification of risk factors, improvements in therapy regimens and advances in treatment delivery have all served to render testis cancer a treatable and survivable malignancy. Institution of specialised oncology centres in the UK to address treatment options for urological cancers has proven to be an effective approach to managing testis cancer by drawing on interdisciplinary expertise and applying insights gained from ongoing R&D. This strategy could become a model for treating other cancers as well.en
dc.languageger-
dc.language.isodeen
dc.subjectTestis Canceren
dc.subjectUrological Canceren
dc.subjectCancer Prognosisen
dc.subjectUnited Kingdomen
dc.titleTestis cancer: the UK as a model.de
dc.typeArticleen
dc.contributor.departmentUrological Oncology, The Christie Hospital NHS Foundation Trust, Wilmslow Road, M20 4BX, Manchester, England.en
dc.identifier.journalDer Urologe. Ausg. Aen
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.